Menu
IPO market
IPO market
Goldline Pharmaceutical IPO is a SME IPO. Issue size is 12 Cr. Price band is ₹41 to ₹43 per share. Minimum investment is ₹2.58 L. Lot size is 3000 shares. Open from 12 May 2026 to 14 May 2026. on 15 May 2026. Listing on 19 May 2026 at BSE. Managed by Cumulative Capital Pvt.Ltd. Registrar: Bigshare Services Pvt Ltd. Key details for GMP, subscription, price, , and listing in one place.
Official documents: RHP.
Price band, lot, minimum application, and issue window at a glance.
Subscription, allotment, refund, share credit, and listing milestones.
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 6,000 | ₹2,58,000 |
| S-HNI (Min) | 3 | 9,000 | ₹3,87,000 |
| S-HNI (UPI) | 3 | 9,000 | ₹3,87,000 |
| S-HNI (Max) | 7 | 21,000 | ₹9,03,000 |
| B-HNI (Min) | 8 | 24,000 | ₹10,32,000 |
From the company / RHP narrative.
How the issuer plans to use IPO proceeds.
Figures from the IPO financial table (₹ Cr). Switch metric to compare years.
Goldline Pharmaceutical IPO
Pre-filled: Issue Price = ₹43, Lot Size = 3,000 shares, Listing Price = ₹59.75
| Category | Lots | Investment | At listing | Profit |
|---|---|---|---|---|
| Retail (Min) | 2 | ₹2,58,000 | ₹60 | +₹1,00,500 |
| S-HNI (Min) | 3 | ₹3,87,000 | ₹60 | +₹1,50,750 |
| S-HNI (UPI) | 3 | ₹3,87,000 | ₹60 | +₹1,50,750 |
| S-HNI (Max) | 7 | ₹9,03,000 | ₹60 | +₹3,51,750 |
| B-HNI (Min) | 8 | ₹10,32,000 | ₹60 | +₹4,02,000 |
Profit based on the official listing price for each investor category.
A quick overview of key terms, dates, and how to track this IPO.
Community ratings and reviews — not financial advice.
No ratings yet — be the first to share your experience.
Reserved portion of the issue by investor category (break data).
